Sign in

CIK 0002044725

  • Emerging growth company

Evommune, Inc.

Sign in to watch
Ticker
EVMN
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
850742575
Phone
+1 650-223-7745
Business address
1891 PAGE MILL RD, PALO ALTO, CA
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-11-13 Patel Jeegar Pravinkumar Chief Scientific Officer Returned to the company · Stock Option (Right to buy) −179,619 0
2026-11-13 Patel Jeegar Pravinkumar Chief Scientific Officer Grant or award · Stock Option (Right to buy) +179,619 179,619
2026-11-13 Patel Jeegar Pravinkumar Chief Scientific Officer Returned to the company · Stock Option (Right to buy) −69,315 0
2026-11-13 Patel Jeegar Pravinkumar Chief Scientific Officer Grant or award · Stock Option (Right to buy) +69,315 69,315
2026-11-13 Drew Janice Suzann Chief of Dev. Operations Returned to the company · Stock Option (Right to buy) −231,274 0
2026-11-13 Drew Janice Suzann Chief of Dev. Operations Grant or award · Stock Option (Right to buy) +231,274 231,274
2026-11-13 Drew Janice Suzann Chief of Dev. Operations Returned to the company · Stock Option (Right to buy) −73,892 0
2026-11-13 Drew Janice Suzann Chief of Dev. Operations Grant or award · Stock Option (Right to buy) +73,892 73,892
2026-11-13 Carver Kyle Chief Financial Officer Returned to the company · Stock Option (Right to buy) −279,408 0
2026-11-13 Carver Kyle Chief Financial Officer Grant or award · Stock Option (Right to buy) +279,408 279,408
2026-11-13 Carver Kyle Chief Financial Officer Returned to the company · Stock Option (Right to buy) −98,946 0
2026-11-13 Carver Kyle Chief Financial Officer Grant or award · Stock Option (Right to buy) +98,946 98,946
2026-11-13 Moss Gregory S. Chief Business & Legal Officer Returned to the company · Stock Option (Right to buy) −293,496 0
2026-11-13 Moss Gregory S. Chief Business & Legal Officer Grant or award · Stock Option (Right to buy) +293,496 293,496
2026-11-13 Moss Gregory S. Chief Business & Legal Officer Returned to the company · Stock Option (Right to buy) −115,279 0
2026-11-13 Moss Gregory S. Chief Business & Legal Officer Grant or award · Stock Option (Right to buy) +115,279 115,279
2026-11-13 Bauer Eugene Chief Medical Officer Returned to the company · Stock Option (Right to buy) −100,000 0
2026-11-13 Bauer Eugene Chief Medical Officer Grant or award · Stock Option (Right to buy) +100,000 100,000
2026-11-13 Bauer Eugene Chief Medical Officer Returned to the company · Stock Option (Right to buy) −51,117 0
2026-11-13 Bauer Eugene Chief Medical Officer Grant or award · Stock Option (Right to buy) +51,117 51,117

Page 1 of 8 · 145 trades